Description

Standard & Poor's Global Industry Surveys help meet the growing demand for in-depth industry analysis from a European, Asian and Latin American perspective. Designed for strategic planners, management consultants, money managers, researchers, business students, and academic faculty, Global Industry Surveys are an excellent way to get up to speed on current events, future trends and the competitive dynamics of leading industries outside of North America. Intended to complement a subscription to Standard & Poor's flagship industry research product - Industry Surveys - each Global Industry Survey will include the following sections: Current Environment, Industry Trends, How the Industry Operates, Key Industry Ratios and Statistics, Glossary, Industry References and Comparative Company Analysis.

Table of Contents

CURRENT ENVIRONMENT Asian governments promote biotech Australian companies aggressively pursue innovation Setbacks for Japanese biotechs WTO shakes up Indian and Chinese biotech industries Korean stem scandal's cautionary tale for ambitious Asians The EU generic biologics opportunity in Asia INDUSTRY PROFILE Biotech gains from a changing Asia Japan slowly gains an edge in biotech Australia makes biotech a priority China invests in innovation India bets on research services, generic biologics, and ag-biotech South Korea, Singapore vie to be hubs INDUSTRY TRENDS China, India draw on low operating costs and skilled labor pool Growing technological capabilities Stem-cell research picks up in Asia where United States left off Traditional Chinese medicine attracts Western interest Governments are advocates Competing via bioparks Asian venture capitalists emerge HOW THE INDUSTRY OPERATES Developing human biologics Bringing a biologic to market Financing a critical component for biotech Critical regulatory issues KEY INDUSTRY RATIOS AND STATISTICS GLOSSARY INDUSTRY REFERENCES COMPARATIVE COMPANY ANALYSIS